wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52724810-C7021D8D-6D04-4DC9-965B-858C498FF1B1
Q52724810-C7021D8D-6D04-4DC9-965B-858C498FF1B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52724810-C7021D8D-6D04-4DC9-965B-858C498FF1B1
Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.
P2860
Q52724810-C7021D8D-6D04-4DC9-965B-858C498FF1B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52724810-C7021D8D-6D04-4DC9-965B-858C498FF1B1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c248de781521ba8d5e6e2da6fafcc75bf1e00ebc
P2860
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.